Presumed Sterile Endophthalmitis Afer Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought?
- PMID: 28161929
- DOI: 10.1097/APO.0000000000000194
Presumed Sterile Endophthalmitis Afer Intravitreal Triamcinolone (Kenalog)-More Common and Less Benign Than We Thought?
Abstract
Purpose: This study aimed to review the incidence and clinical outcome of presumed sterile endophthalmitis after the off-label use of intravitreal Kenalog injections (triamcinolone acetonide with 1.5% benzyl alcohol) and to compare it with the presumed sterile endophthalmitis incidence after intravitreal Kenacort-A (0.99% benzyl alcohol) at our center.
Design: This was a single-center, retrospective, consecutive, interventional case series of all patients who underwent intravitreal Kenalog injections at Hong Kong Eye Hospital from November 1, 2009, to July 31, 2012.
Methods: This was a retrospective medical records review.
Results: A total of 81 intravitreal Kenalog injections were performed. Ten eyes (12.3%) developed presumed sterile endophthalmitis, presenting clinically with dense anterior chamber cells, fibrin, hypopyon, and vitritis. All cases were treated with topical steroids and antibiotics. Although the inflammation resolved eventually in all cases, 2 eyes developed complications, resulting in eventual loss of best corrected visual acuity: one developed rhegmatogenous retinal detachment with choroidal detachment, and another developed vitreous hemorrhage.
Conclusions: The rate of presumed sterile endophthalmitis after Kenalog injection is much higher than our previous experience with Kenacort-A. To the best of our knowledge, this is the first study reporting the incidence of presumed sterile endophthalmitis using intravitreal Kenalog and Kenacort in the same center using the same injection technique. We believe that it may be due to a difference in the concentration of the preservative. Although sterile endophthalmitis is generally thought to run a benign course, this study has shown that serious complications may occur.
Keywords: dosage/adverse effects; endophthalmitis; inflammation; intravitreal injections; retinal diseases/drug therapy; triamcinolone acetonide/administration.
Copyright© 2017 Asia-Pacific Academy of Ophthalmology.
Similar articles
-
[Complications of intravitreal injections--own experience].Klin Oczna. 2011;113(4-6):127-31. Klin Oczna. 2011. PMID: 21913440 Polish.
-
Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.Retina. 2009 Feb;29(2):207-13. doi: 10.1097/IAE.0b013e31818eccb3. Retina. 2009. PMID: 19050670
-
Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.Arch Ophthalmol. 2003 Sep;121(9):1279-82. doi: 10.1001/archopht.121.9.1279. Arch Ophthalmol. 2003. PMID: 12963610
-
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].Ophthalmologe. 2004 Feb;101(2):113-20. doi: 10.1007/s00347-003-0982-0. Ophthalmologe. 2004. PMID: 14991306 Review. German.
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
Cited by
-
Update on corticosteroids for diabetic macular edema.Clin Ophthalmol. 2016 Sep 8;10:1723-30. doi: 10.2147/OPTH.S115546. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27660409 Free PMC article. Review.
-
Endophthalmitis after intravitreal injections versus cataract surgery: a 15-year cohort.Int Ophthalmol. 2020 Jan;40(1):73-79. doi: 10.1007/s10792-019-01153-1. Epub 2019 Aug 14. Int Ophthalmol. 2020. PMID: 31414274
-
Sterile endophthalmitis after intravitreal triamcinolone acetonide injection: A case report series.Ann Med Surg (Lond). 2022 Mar 28;76:103537. doi: 10.1016/j.amsu.2022.103537. eCollection 2022 Apr. Ann Med Surg (Lond). 2022. PMID: 35495379 Free PMC article.
-
Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports.J Med Case Rep. 2021 Oct 22;15(1):518. doi: 10.1186/s13256-021-03129-1. J Med Case Rep. 2021. PMID: 34674724 Free PMC article.
-
Safety and cost-effectiveness of single-use endolaser probe reprocessing in vitreoretinal surgery.Int J Retina Vitreous. 2021 Mar 17;7(1):22. doi: 10.1186/s40942-021-00292-x. Int J Retina Vitreous. 2021. PMID: 33731215 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical